Development of novel therapeutics for glaucoma filtration surgery based on transforming growth factor-β receptor 1 inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of novel therapeutics for glaucoma filtration surgery based on transforming growth factor-β receptor 1 inhibition

Published:2019 Issue:48 Volume:43 Page:19265-19273
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Zivkovic Maja¹²³⁴⁵,Zlatanovic Marko⁶⁷⁵,Zlatanovic Nevena⁸⁴⁵,Golubović Mladjan⁹⁷⁴⁵,Veselinović Aleksandar M.¹¹⁰³⁴⁵^ORCID

Affiliation:

1. Faculty of Medicine

2. Department of Ophthalmology

3. University of Nis

4. Nis

5. Serbia

6. Ophthalmology Clinic

7. Clinical Center Nis

8. Community Health Center Nis

9. Clinic for Anesthesiology and Intensive Care

10. Department of Chemistry

Abstract

QSAR modeling with computer-aided drug design was used for the in silico development of novel therapeutics for glaucoma filtration surgery.

Funder

European Cooperation in Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NJ/C9NJ05393J

Reference57 articles.

1. Growth factors in wound healing

2. TGF-β SIGNAL TRANSDUCTION

3. Transforming Growth Factor type β and Smad family signaling in stem cell function

4. Transforming growth factor βs and wound healing

5. Targeting Genes for Treatment in Idiopathic Pulmonary Fibrosis: Challenges and Opportunities, Promises and Pitfalls

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP